Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs Limited has submitted its financial results for the period ended September 30, 2025 to the stock exchange. This corresponds to the second quarter / first half of FY26 results. The filing itself is a routine compliance notice and does not contain specific revenue, profit, or margin figures. Investors should refer to the detailed results PDF or press release for the actual numbers and segment performance.
Neutral on its own — this is a standard regulatory filing. The real impact on the stock will depend on the actual numbers (revenue growth, margins, profit) disclosed in the detailed results, which are not included in this notice.